首页> Cancers> Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer.

Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Lisa S M,Hofste

第一单位： Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

作者： Lisa S M,Hofste ^[1] ; Maartje J,Geerlings ^[1] ; Daniel,von Rhein ^[1] ; Sofie H,Tolmeijer ^[2] ; Marjan M,Weiss ^[1] ; Christian,Gilissen ^[1] ; Tom,Hofste ^[1] ; Linda M,Garms ^[3] ; Marcel J R,Janssen ^[4] ; Heidi,Rütten ^[5] ; Camiel,Rosman ^[3] ; Rachel S,van der Post ^[6] ; Bastiaan R,Klarenbeek ^[3] ; Marjolijn J L,Ligtenberg ^[7]

作者单位： Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. ^[1] Department of Medical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. ^[2] Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. ^[3] Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. ^[4] Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. ^[5] Department of Pathology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. ^[6] Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.;Department of Pathology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands. ^[7]

关键词 circulating tumor DNA esophageal cancer liquid biopsies neoadjuvant treatment next-generation sequencing

DOI 10.3390/cancers14184417

PMID 36139577

发布时间 2022-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交